A Novel mutation L619F in the cardiac Na+ channel SCN5A associated with long‐QT syndrome (LQT3): a role for the I‐II linker in inactivation gating
暂无分享,去创建一个
Marc Gewillig | Hein Heidbüchel | Pieter A Doevendans | H. Wellens | H. Heidbüchel | R. Kass | X. Wehrens | M. Vos | R. Jongbloed | M. Gewillig | Robert S Kass | Marc A Vos | Xander H T Wehrens | T. Rossenbacker | Hein J J Wellens | Tom Rossenbacker | Roselie J Jongbloed | Pieter A. Doevendans
[1] B. Kerem,et al. Novel LQT-3 Mutation Affects Na+ Channel Activity Through Interactions Between α- and β1-Subunits , 1998 .
[2] F. Cappuccio,et al. Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia , 2002, Science.
[3] S. Priori,et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. , 2000, The New England journal of medicine.
[4] P. Schwartz,et al. Idiopathic long QT syndrome: progress and questions. , 1985, American heart journal.
[5] A. L. Goldin,et al. Interaction between the sodium channel inactivation linker and domain III S4-S5. , 1997, Biophysical journal.
[6] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[7] Robert L. Barchi,et al. Inactivation and Secondary Structure in the D4/S4-5 Region of the SkM1 Sodium Channel , 1998, The Journal of general physiology.
[8] A L Goldin,et al. A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[9] G. Breithardt,et al. De Novo Mutation in the SCN5A Gene Associated With Early Onset of Sudden Infant Death , 2001, Circulation.
[10] A. George,et al. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] W. Catterall,et al. Role of the C-terminal domain in inactivation of brain and cardiac sodium channels , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Schwartz,et al. Multiple mechanisms of Na+ channel--linked long-QT syndrome. , 1996, Circulation research.
[13] A. George,et al. Molecular mechanism for an inherited cardiac arrhythmia , 1995, Nature.
[14] G. Kirsch,et al. Accelerated inactivation in a mutant Na(+) channel associated with idiopathic ventricular fibrillation. , 2001, American journal of physiology. Heart and circulatory physiology.
[15] P. C. Viswanathan,et al. A sodium-channel mutation causes isolated cardiac conduction disease , 2001, Nature.
[16] A. L. Goldin,et al. Amino acid residues required for fast Na(+)-channel inactivation: charge neutralizations and deletions in the III-IV linker. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] W. Catterall,et al. A Critical Role for the S4-S5 Intracellular Loop in Domain IV of the Sodium Channel α-Subunit in Fast Inactivation* , 1998, The Journal of Biological Chemistry.
[18] P. C. Viswanathan,et al. Clinical, Genetic, and Biophysical Characterization of SCN5A Mutations Associated With Atrioventricular Conduction Block , 2002, Circulation.
[19] M. Keating,et al. MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia , 1999, Cell.
[20] A. Wilde,et al. Cardiac conduction defects associate with mutations in SCN5A , 1999, Nature Genetics.
[21] D. Attwell,et al. The steady state TTX-sensitive (“window”) sodium current in cardiac Purkinje fibres , 1979, Pflügers Archiv.
[22] D M Roden,et al. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] S. Priori,et al. Novel Arrhythmogenic Mechanism Revealed by a Long-QT Syndrome Mutation in the Cardiac Na+ Channel , 2001, Circulation research.
[24] Arthur J Moss,et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.
[25] R. Horn,et al. Role of an S4-S5 linker in sodium channel inactivation probed by mutagenesis and a peptide blocker , 1996, The Journal of general physiology.
[26] J Benhorin,et al. Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel alpha-subunit: A computational analysis. , 2000, Circulation.
[27] P. C. Viswanathan,et al. Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes , 2002, Circulation.
[28] G. Breithardt,et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.
[29] H. Bazett,et al. AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS. , 1997 .
[30] S. Priori,et al. Brugada syndrome and sudden cardiac death in children , 2000, The Lancet.
[31] Silvia G Priori,et al. A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction. , 2002, Physiological genomics.